Thong Le
Director Ejecutivo en ALSP ORCHID ACQUISITION CORPORATION I .
Perfil
Thong Q.
Le is the founder of Minimeals, Inc. He currently holds multiple positions including President & Chief Executive Officer at Accelerator Services Corp, Chief Executive Officer & Director at ApoGen Biotechnologies, Inc., Chief Executive Officer & Director at Proniras Corp., Chief Executive Officer at Magnolia Neurosciences Corp., President, Chief Executive Officer & Director at ALSP Orchid Acquisition Corp.
I, Chief Executive Officer & Director at Lydian Neurosciences Corp., Chief Executive Officer & Director at Automera Pte Ltd., Director at Acylin Therapeutics, Inc., Director at Petra Pharma Corp., Director at Briotech, Inc., Independent Director at Oerth Bio LLC, Director at Ravenna Pharmaceuticals, Inc., and CFO at Miro Tea.
He has held former positions including Chief Executive Officer & Director at Oncofactor Corp., Chief Executive Officer & Director at Lodo Therapeutics Corp., President, Chief Executive Officer & Director at Rodeo Therapeutics Corp., Chairman at Washington Biotechnology & Biomedical Association, Director at Teranode, Inc., Director at Recodagen Corp., Director at Groove Biopharma Corp., Director at XORI Corp., Director at AnswerDash, Inc., Managing Director at WRF Capital from 2000 to 2013, Director at Arzeda Corp., Director at AgTech Accelerator Corp., Principal at Raymond James & Associates, Inc., Principal at Capital Management Group, Inc., and Executive Board Member at Life Science Washington from 2011 to 2017.
He obtained his undergraduate degree from Harvard University in 1998.
Cargos activos de Thong Le
| Empresas | Cargo | Inicio |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Director Ejecutivo | - |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Director Ejecutivo | - |
| Miro Tea | Director Financiero/CFO | 01/09/2005 |
Oerth Bio LLC
 Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky. | Director/Miembro de la Junta | 18/01/2022 |
Lydian Neurosciences Corp.
 Lydian Neurosciences Corp. SemiconductorsElectronic Technology Lydian Neurosciences Corp. develops molecules for treatment. Le. The CEO of the American company is Thong Q. | Director Ejecutivo | - |
Briotech, Inc.
 Briotech, Inc. Household/Personal CareConsumer Non-Durables Briotech, Inc. manufactures Hypochlorous Acid product. It offers briotech topical skin spray, obliter8 odor, and briohocl prp formula. The company was founded by Daniel Terry and Cynthia Varela in 2013 and is headquartered in Woodinville, WA. | Director/Miembro de la Junta | - |
| Ravenna Pharmaceuticals, Inc. | Director/Miembro de la Junta | - |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Director Ejecutivo | - |
ApoGen Biotechnologies, Inc.
 ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology ApoGen Biotechnologies, Inc. operates as a biotechnology firm, which focuses on the development of therapeutics targeting drivers of cancer genomic mutation. The company was founded by John T. Santini, Jr., Reuben S. Harris, and Daniel A. Harki in 2014 and is headquartered in Seattle, WA. | Director Ejecutivo | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Antiguos cargos conocidos de Thong Le.
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░ ░░ ░░░░░░░░░░░░░░░░ | - |
Formación de Thong Le.
| Harvard University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 28 |
|---|---|
Raymond James & Associates, Inc.
 Raymond James & Associates, Inc. Financial ConglomeratesFinance Raymond James & Associates, Inc. (RJA) is a registered broker-dealer headquartered in St. Petersburg, Florida. The firm was founded in 1962 and is a subsidiary of Raymond James Financial, Inc. (NYSE: RJF), a diversified holding company. RJA offers a full array of capital markets services, strategic advice and planning for institutional investors. | Finance |
Teranode, Inc.
 Teranode, Inc. Miscellaneous Commercial ServicesCommercial Services Teranode, Inc. provides business intelligence solutions. It offers solutions to bio-pharmaceutical companies, healthcare providers, and payers or insurers. The firm allows real-time listening of twitter, blogs, Facebook and many other sources to track and manage public sentiments proactively. The company was founded by Lawrence F. Arnstein, Zheng Li, Joseph E. Duncan and Neil Fanger in 2002 and is headquartered in Horwich, the United Kingdom. | Commercial Services |
Recodagen Corp.
 Recodagen Corp. Medical SpecialtiesHealth Technology Recodagen Corp. engages in the discovery and development of a class of disease targets, proteins, and products for the treatment of solid tumors in cancer. Recodagen's technology is based upon the discovery of a novel class of disease targets. The first therapeutic indications that the company will pursue are for solid tumors in cancer. The first lead target appears to facilitate tumor cell invasion and dissemination which result in the lethal part of cancer known as metastasis. | Health Technology |
Groove Biopharma Corp.
 Groove Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Groove Biopharma Corp. focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) were involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma's core technology addressed a new avenue of nucleotide therapeutic drug discovery via modulation of cellular mirna. Used exclusive technology, Groove Biopharma were generated a series of lead candidates with the potential to be best-in-class therapeutics. By incorporated proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presented promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.The company was founded in 2008 and is headquartered in Seattle,UN. | Commercial Services |
XORI Corp.
 XORI Corp. BiotechnologyHealth Technology XORI Corp. provides health technology services. It develops technology for the rapid discovery and development of monoclonal antibodies (MAbs). The firm validates the technology on a variety of targets and develops superior products for cancer therapy, immune disorders, and infectious diseases. The company was founded by Nancy Maizels in 2009 and is headquartered in Seattle, WA. | Health Technology |
Oncofactor Corp.
 Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Oncofactor Corp. develops antibody drugs against new biologic targets in cancer. Its cancer therapeutics that disrupt signaling pathways between tumors and the immune system. The company was founded by Sarah Ellen Warren in 2011 and is headquartered in Seattle, WA. | Health Technology |
AnswerDash, Inc.
 AnswerDash, Inc. Specialty TelecommunicationsCommunications AnswerDash, Inc. engages in the provision of context-based answer engine solutions. Its platform enables users to provide selection-based, self-service, point-and-click contextual answers on websites, web applications, and mobile experiences to customers. The company was founded by Jacob O. Wobbrock, Parmit Chilana and Andrew Ko in September 2012 and is headquartered in Seattle, WA. | Communications |
Capital Management Group, Inc.
 Capital Management Group, Inc. Investment ManagersFinance Capital Management Group, Inc. (CMG) is an independent, SEC-registered investment advisor headquartered in Wheaton, Illinois. Founded in 2000, CMG provides investment management services to individuals, businesses, trusts, and employee benefit plans. | Finance |
WRF Capital
 WRF Capital Investment ManagersFinance WRF Capital (WRF Capital) is a venture capital firm founded in 1994 by Ronald Howell. The firm is headquartered in Seattle, Washington. | Finance |
| Washington Biotechnology & Biomedical Association | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Arzeda Corp.
 Arzeda Corp. BiotechnologyHealth Technology Arzeda Corp. operates as a synthetic biology company. It works thru agriculture, functionalized sweeteners and ingredients, chemicals and materials, and pharmaceuticals and diagnostics. The company was founded by Eric Althoff, David Baker, Daniela Grabs-R?thlisberger, Michael A. Martino and Alexandre Zanghellini in 2008 and is headquartered in Seattle, WA. | Health Technology |
Acylin Therapeutics, Inc.
 Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Health Technology |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Health Technology |
Petra Pharma Corp.
Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Health Technology |
AgTech Accelerator Corp.
 AgTech Accelerator Corp. Financial ConglomeratesFinance AgTech Accelerator Corp. focuses on discovering and developing agricultural technology companies. It offers finance to agricultural firms. The company was founded in 2003 and is headquartered in Durham, NC. | Finance |
Briotech, Inc.
Briotech, Inc. Household/Personal CareConsumer Non-Durables Briotech, Inc. manufactures Hypochlorous Acid product. It offers briotech topical skin spray, obliter8 odor, and briohocl prp formula. The company was founded by Daniel Terry and Cynthia Varela in 2013 and is headquartered in Woodinville, WA. | Consumer Non-Durables |
ApoGen Biotechnologies, Inc.
ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology ApoGen Biotechnologies, Inc. operates as a biotechnology firm, which focuses on the development of therapeutics targeting drivers of cancer genomic mutation. The company was founded by John T. Santini, Jr., Reuben S. Harris, and Daniel A. Harki in 2014 and is headquartered in Seattle, WA. | Health Technology |
Rodeo Therapeutics Corp.
 Rodeo Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Rodeo Therapeutics Corp. engages in the development of drugs. The firm develops novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant. It focuses on the development of small-molecule therapies that increase tissue levels of prostaglandin PGE2. The company was founded by Stanton Gerson, Sanford Markowitz, and Joseph Ready on May 15, 2017 and is headquartered in Seattle, WA. | Health Technology |
Proniras Corp.
Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Health Technology |
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Health Technology |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky. | Health Technology |
| Life Science Washington | |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance ALSP Orchid Acquisition Corp. I is a blank check company. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on August 31, 2021 and is headquartered in Seattle, WA. | Finance |
| Minimeals, Inc. | |
| Ravenna Pharmaceuticals, Inc. | |
Lydian Neurosciences Corp.
Lydian Neurosciences Corp. SemiconductorsElectronic Technology Lydian Neurosciences Corp. develops molecules for treatment. Le. The CEO of the American company is Thong Q. | Electronic Technology |
| Miro Tea |
- Bolsa de valores
- Insiders
- Thong Le
